Noriko Yamamoto

Dr. Noriko Yamamoto

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Hepatogastroenterology
Verified
Journal Article
Closed access
MTMasanori Tokunaga
Masanori Tokunaga
SOShigekazu Ohyama
Shigekazu Ohyama
NHNaoki Hiki
Naoki Hiki
TFTetsu Fukunaga
Tetsu Fukunaga
NYNoriko Yamamoto
Noriko Yamamoto
TYToshiharu Yamaguchi
Toshiharu Yamaguchi
Surgical R0 resection is a mainstay of treatment for gastrointestinal stromal tumor (GIST) of the stomach. The incidence of lymph node metastasis (LNM) has been reported as extremely low. However, the actual incidence of LNM still remains unclear due to the limited number of patients who underwent systemic lymph node dissection. Fifty-seven patients who underwent gastrectomy with systemic lymphadenectomy for c-Kit-positive GIST of the stomach at the Cancer Institute Hospital between 1970 and 2000 were included. The clinicopathological characteristics of the patients were used to clarify the incidence and prognostic value of LNM in patients with GIST of the stomach. R0 resection was achieved in 52/57 patients. The 5-year survival rate of patients following R0 resection was 68.6%. LNM was observed in 5/57 (8.8%) patients. All 5 patients died within 5 years after surgery even though 3 had undergone curative surgery. In patients with GIST of the stomach, the incidence of LNM following systemic lymphadenectomy is low. The prognosis of patients with LNM was poor; thus it should be regarded as an advanced disease.

1 December 2009 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ISIwao Sugitani
Iwao Sugitani
KTKazuhisa Toda
Kazuhisa Toda
NYNoriko Yamamoto
Noriko Yamamoto
ASAtsuhiko Sakamoto
Atsuhiko Sakamoto
YFYoshihide Fujimoto
Yoshihide Fujimoto

17 August 2012 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
SKSatoru Karasawa
Satoru Karasawa
KNKimihiro Nakano
Kimihiro Nakano
JTJun-Ichi Tanokashira
Jun-Ichi Tanokashira
NYNoriko Yamamoto
Noriko Yamamoto
TYTakahito Yoshizaki
Takahito Yoshizaki
NKNoboru Koga
Noboru Koga
The microcrystalline sample of a parent complex, [CoCl2(py)4], showed a single-molecule magnet (SMM) behavior with an effective activation barrier, Ueff/kB, of 16 K for reversal of the magnetism in the presence of a dc field of 3 kOe. Pyridine ligands having 2–4 diazo moieties, DYpy; Y = 2, 3l, 3b, and 4, were prepared and confirmed to be quintet, septet, septet, and nonet in the ground state, respectively, after irradiation. The 1 : 4 complexes, CoCl2(DYpy)4; Y = 2, 3l, 3b, and 4 in frozen solutions after irradiation showed the magnetic behaviors of SMMs with total spin multiplicity, Stotal = 17/2, 25/2, 25/2, and 33/2, respectively. Hysteresis loops depending on the temperature were observed and the values of coercive force, Hc, at 1.9 K were 12, 8.4, 11, and 8.1 kOe for CoCl2(CYpy)4; Y = 2, 3l, 3b, and 4, respectively. In dynamic magnetic susceptibility experiments, ac magnetic susceptibility data obeyed the Arrhenius law to give Ueff/kB values of 94, 92, 93, and 87 K for CoCl2(CYpy)4; Y = 2, 3l, 3b, and 4, respectively, while the relaxation times for CoCl2(CYpy)4; Y = 2 and 3l, obtained by dc magnetization decay in the range of 3.5–1.9 K slightly deviated downward from Arrhenius plots on cooling. The dynamic magnetic behaviors for CoCl2(CYpy)4 including [CoCl2(py)4] and CoCl2(C1py)4 suggested that the generated carbenes interacted with the cobalt ion to increase the relaxation time, τq, due to the spin quantum tunneling magnetization, which became larger with increasing Stotal of the complex.

21 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YHYusuke Horiuchi
Yusuke Horiuchi
JFJunko Fujisaki
Junko Fujisaki
NYNoriko Yamamoto
Noriko Yamamoto
NINaoki Ishizuka
Naoki Ishizuka
AIAkiyoshi Ishiyama
Akiyoshi Ishiyama
TTTomohiro Tsuchida
Tomohiro Tsuchida
We aimed to clarify the differences in therapeutic outcomes of patients with pure undifferentiated-type and mixed undifferentiated-type cancers who underwent endoscopic submucosal dissection (ESD), and whether pre-treatment diagnosis of mixed undifferentiated-type cancer is associated with requiring additional surgery after ESD. Patients subjected to ESD as initial treatment between May 2005 and March 2017 were enrolled. There were 277 undifferentiated-type cancers (265 patients). Histologically, 258 lesions were pure-type and 19 were mixed-type. We compared therapeutic outcomes and pre-treatment factors (tumour diameter, tumour depth, ulcerative findings, tumour location, and the macroscopic, and histological type of the biopsy specimen) between pure-type and mixed-type lesions, and between cases not requiring additional surgeries and cases requiring additional surgeries. Tumour diameter >20 mm, submucosal invasion, and the presence of ulcerative findings made pre-treatment diagnosis more difficult for mixed-type than for pure-type lesions. In cases requiring additional surgery, pre-treatment diagnosis of mixed-type lesions was significantly more likely than pre-treatment diagnosis of pure-type lesions. For mixed-type lesions, pre-treatment histological diagnosis and careful consideration are necessary to determine indications for ESD to avoid additional surgery after ESD.

1 January 2007 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
HYHiroyuki Yonekawa
Hiroyuki Yonekawa
ISIwao Sugitani
Iwao Sugitani
YFYoshihide Fujimoto
Yoshihide Fujimoto
MAMasami Arai
Masami Arai
NYNoriko Yamamoto
Noriko Yamamoto
Since the majority of multiple endocrine neoplasia type 2A (MEN 2A) patients have missense mutations at codon 634 and those with the Cys630 RET genotype mutations are extremely rare, limited clinical information is available about this rare type. We report here three members of one Japanese MEN 2A family with the Cys630Tyr genotype. A 67-year-old woman presented a firm thyroid nodule, and preoperative examination revealed medullary thyroid carcinoma with primary hyperparthyoidism and no pheochromocytoma. At surgery, bilateral medullary thyroid carcinomas and parathyroid adenoma were found. No lymph node metastasis was identified. Computed tomography scans and laboratory examination of blood have shown no evidence of tumor recurrence and no abnormality of parathyroid function during the 4 years after surgery. A 40-year-old man, the proband's son, was shown to have the same RET mutation, underwent total thyroidectomy prophylactically, and only microscopic foci of medullary thyroid carcinoma were found. A 10-year-old boy, the proband's grandson also having the same RET mutation, showed normal basal serum calcitonin level and has been followed up conservatively. To our knowledge, 18 patients of 6 families with the Cys630 mutations have been reported so far. This is only the second reported case with primary hyperparathyroidism. RET 630 mutations might be associated with lower penetrance of primary hyperparthyoidism and pheochromocytoma.

1 February 1996 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NYNoriko Yamamoto
Noriko Yamamoto
KYKoichi Yokota
Koichi Yokota
AYAkira Yamashita
Akira Yamashita
MOMinoru Oda
Minoru Oda